Deutsche Bank Initiates CONMED With Buy

Loading...
Loading...
Analysts at Deutsche Bank initiated coverage on
CONMED CorporationCNMD
with a Buy rating. The target price for CONMED is set to $63. CONMED shares have gained 7.29 percent over the past 52 weeks, while the S&P 500 index has surged 11.87 percent in the same period. CONMED shares closed at $50.16 on Friday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: InitiationAnalyst RatingsDeutsche Bank
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...